Gene D. Morse, PharmD, FCCP, BCPS

He also is co-director of the SUNY Global Health Institute. Morse has been actively involved in HIV clinical pharmacology research since the introduction of antiretrovirals in 1986, with more recent emphasis on HCV infection and drug development. He has National Institute of Allergy and Infectious Diseases support for the UB AIDS Clinical Trials Group, Pharmacology Specialty Laboratory and a contract for the HIV Clinical Pharmacology Quality Assurance Program. These programs integrate with the NIH Fogarty International Center AIDS International Training and Research Program, which Morse directs with the University of Zimbabwe and is home to the Center of Excellence in Clinical Pharmacology.

Morse also directs the UB HIV and HCV Clinical Pharmacology Laboratory, which has gained an international reputation for its work in bioanalysis, pharmacokinetics and pharmacogenomics. He is director of the Empire State Patient Safety Assurance Network,  a network for health information technology innovation. Within the UB Clinical and Translational Science Institute he is the Drug Development Core and  Translational Research Workforce Development Associate Director. In addition, he is associate director for the Clinical Trials Methods and Technologies Pillar for the Clinical and Translational Sciences Institute at the University of Rochester Medical Center.

Morse is co-founder of the Buffalo Jamaica Innovation Enterprise, a partnership between UB, the University of the West Indies, Mona Campus and the Jamaica Ministry of Health. This project has established the Jamaica Center for Infectious Diseases Research and begun a research capacity building collaboration with SUNY and the University of the West Indies. Morse has more than 25 years of NIH, industry and philanthropic research support with extensive experience in grant applications and mentoring. He received the 2012 Volwiler Research Achievement Award from the American Association of Colleges of Pharmacy.